» Articles » PMID: 32348736

Pediatric Cancer Models in Zebrafish

Overview
Journal Trends Cancer
Publisher Cell Press
Specialty Oncology
Date 2020 Apr 30
PMID 32348736
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Pediatric cancer is a leading cause of death in children and adolescents. Improvements in pediatric cancer treatment that include the alleviation of long-term adverse effects require a deeper understanding of the genetic, epigenetic, and developmental factors driving these cancers. Here, we review how the unique attributes of the zebrafish model system in embryology, imaging, and scalability have been used to identify new mechanisms of tumor initiation, progression, and relapse and for drug discovery. We focus on zebrafish models of leukemias, neural tumors and sarcomas - the most common and difficult childhood cancers to treat.

Citing Articles

Establishment and application of a zebrafish model of Werner syndrome identifies sapanisertib as a potential antiaging drug.

Ma J, Chen Y, Song J, Ruan Q, Li L, Luo L Proc Natl Acad Sci U S A. 2025; 122(5):e2413719122.

PMID: 39883840 PMC: 11804616. DOI: 10.1073/pnas.2413719122.


CRISPR-based functional genomics for schistosomes and related flatworms.

Ittiprasert W, Brindley P Trends Parasitol. 2024; 40(11):1016-1028.

PMID: 39426911 PMC: 11560492. DOI: 10.1016/j.pt.2024.09.010.


Uveal Melanoma Zebrafish Xenograft Models Illustrate the Mutation Status-Dependent Effect of Compound Synergism or Antagonism.

van den Bosch Q, Kilic E, Brosens E Invest Ophthalmol Vis Sci. 2024; 65(10):26.

PMID: 39163035 PMC: 11346061. DOI: 10.1167/iovs.65.10.26.


A simple and scalable zebrafish model of Sonic hedgehog medulloblastoma.

Casey M, Chan P, Li Q, Zu J, Jette C, Kohler M Cell Rep. 2024; 43(8):114559.

PMID: 39078737 PMC: 11404834. DOI: 10.1016/j.celrep.2024.114559.


Preparation, Characterization, and Antioxidant Activities of Extracts from L. Flowers.

Yu Q, Li W, Liang M, Li G, Wu Z, Long J Molecules. 2024; 29(3).

PMID: 38338377 PMC: 10856188. DOI: 10.3390/molecules29030633.


References
1.
Shern J, Yohe M, Khan J . Pediatric Rhabdomyosarcoma. Crit Rev Oncog. 2015; 20(3-4):227-43. PMC: 5486973. DOI: 10.1615/critrevoncog.2015013800. View

2.
Ward E, DeSantis C, Robbins A, Kohler B, Jemal A . Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin. 2014; 64(2):83-103. DOI: 10.3322/caac.21219. View

3.
Zhang J, Walsh M, Wu G, Edmonson M, Gruber T, Easton J . Germline Mutations in Predisposition Genes in Pediatric Cancer. N Engl J Med. 2015; 373(24):2336-2346. PMC: 4734119. DOI: 10.1056/NEJMoa1508054. View

4.
Banerjee A, Jakacki R, Onar-Thomas A, Wu S, Nicolaides T, Poussaint T . A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study. Neuro Oncol. 2017; 19(8):1135-1144. PMC: 5570236. DOI: 10.1093/neuonc/now282. View

5.
Gutierrez A, Grebliunaite R, Feng H, Kozakewich E, Zhu S, Guo F . Pten mediates Myc oncogene dependence in a conditional zebrafish model of T cell acute lymphoblastic leukemia. J Exp Med. 2011; 208(8):1595-603. PMC: 3149218. DOI: 10.1084/jem.20101691. View